The RIQAS Therapeutic Drug Proficiency Testing (PT) programme is designed to monitor the performance of an impressive 18 therapeutic drugs. Weighed in values are reported for each parameter.
Key Benefits
Lyophilised material for enhanced stability
Worlds largest Proficiency Testing (PT) scheme ensuring peer groups are maximised
Bi-Weekly reporting for early identification of test system errors